IHC staining of HCC organoids and the corresponding primary tumor tissues showed that lenvatinib‐resistant organoids and tumor tissues exhibited elevated expression levels of HECTD2 and NRF2, along with reduced KEAP1 expression (Figure S8E, Supporting Information). This evidence concerns the gene HECTD2 and neoplasm.